Premium
MedWatch: an important instrument for postlicensing surveillance
Author(s) -
ALEDORT L. M.
Publication year - 2006
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2006.02023.x
Subject(s) - medicine , dabigatran , rivaroxaban , recombinant factor viia , scopus , adverse effect , incidence (geometry) , apixaban , thrombosis , risk factor , recombinant dna , factor viia , coagulation , medline , warfarin , tissue factor , atrial fibrillation , biochemistry , chemistry , physics , optics , political science , law , gene